A new technical paper titled “Exploring Uncore Frequency Scaling for Heterogeneous Computing” was published by researchers at ...

Takes you closer to the games, movies and TV you love ...

We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...

Q4 2024 Earnings Call February 12, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne - ...

Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...

New Gold Inc. ("New Gold" or the "Company") (TSX: NGD) (NYSE American: NGD) is pleased to provide its three-year operational outlook and announces the filing of Technical Reports for the New Afton and ...

Delivered on all key guidance metricsAchieved record free cash flow of more than $1.3 billion and repaid $800 million of debtStrong three-year ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today reported its financial results for ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be ...

SOUTH SAN FRANCISCO, CA, USA I 12, 2025 I Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug ...

Welcome to The Trade Desk fourth quarter and full year 2024 earnings conference call. [Operator instructions] Please note, ...